Sunesis Pharmaceuticals (SNSS)

Add to Watchlists Create an Alert
5.50 -0.11  -1.96%   NASDAQ May 22, 4:59PM BATS Real time Currency in USD

Sunesis Pharmaceuticals Cash from Financing TTM:

37.64M for Dec. 31, 2012
View Full Chart

Sunesis Pharmaceuticals Cash from Financing TTM Chart

    Sunesis Pharmaceuticals Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 37.64M
    Sept. 30, 2012 43.56M
    June 30, 2012 10.15M
    March 31, 2012 11.69M
    Dec. 31, 2011 13.75M
    Sept. 30, 2011 21.02M
    June 30, 2011 19.52M
    March 31, 2011 56.35M
    Dec. 31, 2010 68.43M
    Sept. 30, 2010 56.15M
    June 30, 2010 57.63M
    March 31, 2010 27.61M
    Dec. 31, 2009 13.45M
       
    Sept. 30, 2009 7.214M
    June 30, 2009 6.978M
    March 31, 2009 -1.984M
    Dec. 31, 2008 -2.24M
    Sept. 30, 2008 -0.5777M
    June 30, 2008 -0.2635M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    SNSS Cash from Financing TTM Benchmarks

    Companies
    Biogen Idec -699.64M
    Curis 35.82M
    Cell Therapeutics 96.94M

    SNSS Cash from Financing TTM Rankings

    Overall 86th percentile
    1102 of 8005
    Sector 81st percentile
    125 of 686 in Healthcare
    Industry 75th percentile
    61 of 248 in Biotechnology

    SNSS Cash from Financing TTM Range, Past 5 Years

    Minimum -2.240M Dec 2008
    Maximum 68.43M Dec 2010
    Average 23.48M